Top

Published in:

01-04-2016 | Research

Roles of Carbonic Anhydrase IX in Development of Pancreatic Cancer

Authors: Yuji Li, Ming Dong, Weiwei Sheng, Longping Huang

Published in: Pathology & Oncology Research | Issue 2/2016

Abstract

The aim of this study was to study the effects of carbonic anhydrase IX (CA IX) towards the invasion and metastasis of pancreatic cancer. The expressions of CA IX in 58 cases of pancreatic cancer and paired paracancerous normal tissues, obtained from 2005 to 2012 in the first Affiliated Hospital of China Medical University, were detected, as well as its expressions in different pancreatic cancer cell lines, aiming to detect the impacts of CA IX silencing towards the invasion and metastasis of pancreatic cancer cells. The CA IX expressions in 58 pancreatic cancer cases were higher than those in the paired paracancerous normal tissues (P < 0.01), and positively correlated with the tumor size and the UICC staging UICC (P < 0.05), the multivariate analysis showed that the high expression of CA IX was the independent risk factor towards the prognosis of pancreatic cancer (P < 0.05). The CA IX was highly expressed in AxPC–1 and Miapaca–2, and the interference effects were significant. CA IX silencing could significantly inhibit the invasion and metastasis of AxPC-1 and Miapaca. We support a pro-tumor role of CA IX in the development and progression of pancreatic cancer.

Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics. CA Cancer J Clin 60:277–300. doi:10.3322/caac.20073 CrossRefPubMed

Philip PA, Mooney M, Jaffe D, Eckhardt G, Moore M, Meropol N, Emens L, O’Reilly E, Korc M, Ellis L, Benedetti J, Rothenberg M, Willett C, Tempero M, Lowy A, Abbruzzese J, Simeone D, Hingorani S, Berlin J, Tepper J (2009) Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment. J Clin Oncol 27:5660–5669. doi:10.1200/JCO.2009.21.9022 CrossRefPubMed

Ivanov S, Liao SY, Ivanova A, Danilkovitch-Miagkova A, Tarasova N, Weirich G, Merrill MJ, Proescholdt MA, Oldfield EH, Lee J, Zavada J, Waheed A, Sly W, Lerman MI, Stanbridge EJ (2001) Expression of hypoxia-induc-ible cell-surface transmembrane carbonic anhydrase in human cancer. Am J Pathol 158:905–919. doi:10.1016/S0002-9440(10)64038-2 CrossRefPubMedPubMedCentral

Sundfor K, LyngH REK (1998) Tumour hypoxia and vascular density as predictors of metastasis in squamouscell carcinoma of the uterine cervix. Br J Cancer 78:822–827CrossRefPubMedPubMedCentral

Brizel DM, ScullySP HJM, Layfield LJ, Bean JM, Prosnitz LR, Dewhirst MW (1996) Tumor oxygenation predicts for the likelihood of distant metastases in humans of tissue sarcoma. Cancer Res 56:941–943PubMed

Kim SJ, Rabbani ZN, Dewhirst MW, Vujaskovic Z, Vollmer RT, Schreiber EG, Oosterwijk E, Kelley MJ (2005) Expression of HIF-1, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer. Lung Cancer 49:325–335. doi:10.1016/j.lungcan.2005.03.036 CrossRefPubMed

Klatte T, Seligson DB, Rao JY, Yu H, de Martino M, Kawaoka K, Wong SG, Belldegrun AS, Pantuck AJ (2009) Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and the rapeutic moleeular marker. Cancer 115:1448–1458. doi:10.1002/cncr.24163 CrossRefPubMed

Rasheed S, Harris AL, Tekkis PP, Turley H, Silver A, McDonald PJ, Talbot IC, Glynne-Jones R, Northover JM, Guenther T (2009) Assessment of microvessel density and carbonic anhydrase-9 (CA- 9) expression in rectal cancer. Pathol Res Pract 205:1–9. doi:10.1016/j.prp.2008.08.008 CrossRefPubMed

Choueiri TK, Regan MM, Rosenberg JE, Oh WK, Clement J, Amato AM, McDermott D, Cho DC, Atkins MB, Signoretti S (2010) Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear- cell renal cell carcinoma receiving vascular endothelia growth factor- targeted therapy. BJU Int 106:772–778. doi:10.1111/j.1464-410X.2010.09218.x CrossRefPubMed

10.

Robertson N, Potter C, Harris AL (2004) Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion. Cancer Res 64:6160–6165. doi:10.1158/0008-5472.CAN-03-2224 CrossRefPubMed

11.

Juhász M, Chen J, Lendeckel U, Kellner U, Kasper HU, Tulassay Z, Pastorekova S, Malfertheiner P, Ebert MP (2003) Expression of carbonic anhydrase IX in human pancreatic cancer. Aliment Pharmacol Ther 18:837–846, pii:1738 CrossRefPubMed

12.

Sheng W, Dong M, Zhou J, Li X, Dong Q (2013) Down regulation of CAII is associated with tumor differentiation and poor prognosis in patients with pancreatic cancer. J Surg Oncol 107:536–543. doi:10.1002/jso.23282 CrossRefPubMed

13.

Masunaga R, Kohno H, Dhar DK, Ohno S, Shibakita M, Kinugasa S, Yoshimura H, Tachibana M, Kubota H, Nagasue N (2000) Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin Cancer Res 6:4064–4068PubMed

14.

Stathis A, Moore MJ (2010) Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol 7:163–172. doi:10.1038/nrclinonc.2009.236 CrossRefPubMed

15.

Kivelä AJ, Parkkila S, Saarnio J, Karttunen TJ, Kivelä J, Parkkila AK, Pastoreková S, Pastorek J, Waheed A, Sly WS, Rajaniemi H (2000) Expression of transmembrane carbonic anhydrase isoenzymes IX and XII in normal human pancreas and pancreatic tumours. Histochem Cell Biol 114:197–204PubMed

16.

Kivela AJ, Saarnio J, Karttunen TJ, Kivelä J, Parkkila AK, Pastorekova S, Pastorek J, Waheed A, Sly WS, Parkkila TS, Rajaniemi H (2001) Differential expression of cytoplasmic carbonic anhydrases, CA I and II, and membrane-associated isozymes, CA IX and XII, in normal mucosa of large intestine and in colorectal tumors. Dig Dis Sci 46:2179–2186CrossRefPubMed

17.

Kim SJ, Rabbani ZN, Vollmer RT, Schreiber EG, Oosterwijk E, Dewhirst MW, Vujaskovic Z, Kelley MJ (2004) Carbonic anhydrase IX in early-stage non small cell lung cancer. Clin Cancer Res 10:7925–7933. doi:10.1158/1078-0432.CCR-04-0636 CrossRefPubMed

18.

Choschzick M, Oosterwijk E, Müller V, Woelber L, Simon R, Moch H, Tennstedt P (2011) Overexpression of carbonic anhydrase IX (CA IX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer. Virchows Arch 459:193–200. doi:10.1007/s00428-011-1105-y CrossRefPubMed

19.

Schutze D, Milde-Langosch K, Witzel I, Rody A, Karn T, Schmidt M, Choschzick M, Jänicke F, Müller V (2013) Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer. J Cancer Res Clin Oncol 139:747–754. doi:10.1007/s00432-013-1378-4 CrossRefPubMed

20.

Li MP, Ren LF, Cai HG, Yang HY, Lu B, Zhang P, Bao L (2013) Significance of carbonic anhydrase IX protein expression in molecular subtyping of breast cancers. Zhonghua Bing Li Xue Za Zhi 42:182–185. doi:10.3760/cma.j.issn. 0529-5807.2013.03.009 PubMed

21.

En-ping BA, Ya-li LV, Lin LIU, Bo ZHAO (2011) Expression of carbonic anhydrase-9 correlates with malignant phenotypes of invasive breast ductal carcinoma. Chin J Clinicians (Electronic Edition) 5:4656–4660. doi:10.3877/cma.j.issn. 1674-0785.2011.16.083

22.

Simi L, Venturini G, Malentacchi F, Gelmini S, Andreani M, Janni A, Pastorekova S, Supuran CT, Pazzagli M, Orlando C (2006) Quantitative analysis of carbonic anhydrase IXmRNA in human non-small cell lung cancer. Lung Cancer 52:59–66. doi:10.1016/j.lungcan.2005.11.017 CrossRefPubMed

23.

Klimowicz AC, Bose P, Petrillo SK, Magliocco AM, Dort JC, Brockton NT (2013) The prognostic impact of a combined carbonic anhydrase IX and Ki67 signature in oral squamous cell carcinoma. Br J Cancer 109:1859–1866. doi:10.1038/bjc.2013.533 CrossRefPubMedPubMedCentral

24.

Kim SJ, Shin HJ, Jung KY, Baek SK, Shin BK, Choi J, Kim BS, Shin SW, Kim YH, Kim JS, Oosterwijk E (2007) Prognostic value of carbonic anhydrase IX and Ki-67 exression in squamous cell carcinoma of the tongue. J Clin Onco 37:812–819. doi:10.1093/jjco/hym121

25.

Shin HJ, Rho SB, Jung DC, Han IO, Oh ES, Kim JY (2011) Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion. J Cell Sci 124:1077–1087. doi:10.1242/jcs.072207 CrossRefPubMed

26.

Lou Y, McDonald PC, Oloumi A, Chia S, Ostlund C, Ahmadi A, Kyle A, Auf dem Keller U, Leung S, Huntsman D, Clarke B, Sutherland BW, Waterhouse D, Bally M, Roskelley C, Overall CM, Minchinton A, Pacchiano F, Carta F, Scozzafava A, Touisni N, Winum JY, Supuran CT, Dedhar S (2011) Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res 71:3364–3376. doi:10.1158/0008-5472.CAN-10-4261 CrossRefPubMed

27.

De Craene B, Berx G (2013) Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 13:97–110. doi:10.1038/nrc3447 CrossRefPubMed

Title: Roles of Carbonic Anhydrase IX in Development of Pancreatic Cancer
Authors: Yuji Li
Ming Dong
Weiwei Sheng
Longping Huang
Publication date: 01-04-2016
Publisher: Springer Netherlands
Published in: Pathology & Oncology Research / Issue 2/2016
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI: https://doi.org/10.1007/s12253-015-9935-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2016

ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer

Contribution of EVX1 in Aggressiveness of Esophageal Squamous Cell Carcinoma

Isolation and Characterization of a Murine Spontaneous High-Grade Follicular Lymphoma with Restricted In Vivo Spreading – a Model for Lymphatic Metastasis Via the Mesentery

L744,832 and Everolimus Induce Cytotoxic and Cytostatic Effects in Non-Hodgkin Lymphoma Cells

Clinical and Molecular Diagnostic Evaluation of Systemic Mastocytosis in the South-Eastern Hungarian Population Between 2001–2013 – A Single Centre Experience

Evaluation of Toll-Like Receptors 2/3/4/9 Gene Polymorphisms in Cervical Cancer Evolution

Keynote webinar | Spotlight on antibody–drug conjugates in cancer